What type of study is this?

This is a Meta-Analysis study (also classified as: Systematic Review).

December 8, 2025Blood

Bleeding rates in patients with congenital hemophilia B without inhibitors: A systematic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Increased annualized bleeding rates were observed, with over 2 events per year in patients with hemophilia B.
The analysis included 66 studies, yielding a combined mean for treated ABR at 2.26 (95% confidence interval).
Meta-analysis combining clinical trials and observational studies highlighted variability in bleeding rate definitions.
Findings suggest the need for consistent ABR definitions to improve clinical decision-making and address unmet patient needs.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Systematic review finds annualized bleeding rates differ in hemophilia B, indicating unmet needs for patients receiving gene therapy and clinical trials.

Cite This Study

Steven W. Pipe (2025) studied this question.

synapsesocial.com/papers/69362f5a4fa91c937236dbaf https://doi.org/10.1182/blood-2025-6613

View Full Paper

Ask AI

Bookmark

Implication

Systematic review finds annualized bleeding rates differ in hemophilia B, indicating unmet needs for patients receiving gene therapy and clinical trials.

Bleeding rates in patients with congenital hemophilia B without inhibitors: A systematic review and meta-analysis

Key Points

Discussion

Implication

Cite This Study

Bleeding rates in patients with congenital hemophilia B without inhibitors: A systematic review and meta-analysis

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider